{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-112054","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.916128+00:00","generated_at":"2026-05-30T08:54:50.617901+00:00","sec_items":["1.01","3.02","5.01","5.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"GlycoMimetics merges with Crescent in reverse acquisition; uproleselan trial fails","bullets":["Crescent stockholders will own ~86.21% of combined company; GlycoMimetics stockholders ~13.79%.","Concurrent $200M PIPE financing from institutional investors; closing conditioned on merger.","NCI Phase 2/3 trial of uproleselan in AML failed to show statistically significant improvement in EFS or OS.","Merger expected to close in Q2 2025; combined company to be led by Crescent's CEO and board.","Support agreements cover ~98% of Crescent stock and ~9% of GlycoMimetics stock; 180-day lock-up."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-112054","json":"https://secwatch.observer/filing/0001104659-24-112054.json","markdown":"https://secwatch.observer/filing/0001104659-24-112054.md","text":"https://secwatch.observer/filing/0001104659-24-112054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000110465924112054/0001104659-24-112054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000110465924112054/tm2427013d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:54:50.617901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}